Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma
暂无分享,去创建一个
Joachim Thiery | Christos T. Nakas | Tim Conrad | Uta Ceglarek | Alexander Benedikt Leichtle | U. Ceglarek | J. Thiery | A. Leichtle | G. Fiedler | T. Conrad | J. Kase | Peter Weinert | Jean-Marc Nuoffer | Julia Kase | Helmut Witzigmann | Georg Martin Fiedler | J. Nuoffer | H. Witzigmann | C. Nakas | Peter Weinert
[1] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[2] S. Pereira,et al. Diagnosing and managing pancreatic cancer. , 2011, The Practitioner.
[3] Oliver F Bathe,et al. Feasibility of Identifying Pancreatic Cancer Based on Serum Metabolomics , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[4] B. Kholodenko,et al. Computational Approaches for Analyzing Information Flow in Biological Networks , 2012, Science Signaling.
[5] W. Uhl,et al. Amino Acid Malnutrition in Patients With Chronic Pancreatitis and Pancreatic Carcinoma , 2009, Pancreas.
[6] S. Pauls,et al. Evidence-based diagnosis and staging of pancreatic cancer. , 2006, Best practice & research. Clinical gastroenterology.
[7] Tao-Tao Liu,et al. Differentiation of autoimmune pancreatitis with pancreatic carcinoma remains a challenge to physicians , 2012, Journal of digestive diseases.
[8] J P Leigh,et al. Assessing the importance of an independent variable in multiple regression: is stepwise unwise? , 1988, Journal of clinical epidemiology.
[9] U. Ceglarek,et al. Preanalytical standardization of amino acid and acylcarnitine metabolite profiling in human blood using tandem mass spectrometry , 2011, Metabolomics.
[10] Jingjing Xu,et al. Metabolomic Profiling of Serum from Human Pancreatic Cancer Patients Using 1H NMR Spectroscopy and Principal Component Analysis , 2011, Applied biochemistry and biotechnology.
[11] Frank Klawonn,et al. An Alternative to ROC and AUC Analysis of Classifiers , 2011, IDA.
[12] Xue Gu,et al. Metabolomic profiling of human plasma in pancreatic cancer using pressurized capillary electrochromatography , 2011, Electrophoresis.
[13] Reinhard Laubenbacher,et al. Bioinformatics tools for cancer metabolomics , 2011, Metabolomics.
[14] K. Strimmer,et al. Statistical Applications in Genetics and Molecular Biology High-Dimensional Regression and Variable Selection Using CAR Scores , 2011 .
[15] E. Mascha. Equivalence and noninferiority testing in anesthesiology research. , 2010, Anesthesiology.
[16] John P Klein,et al. Methods for equivalence and noninferiority testing. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[17] David Elashoff,et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. , 2010, Gastroenterology.
[18] D. J. Murdoch,et al. A Graphical Display of Large Correlation Matrices , 1996 .
[19] E. Lesaffre. Superiority, equivalence, and non-inferiority trials. , 2008, Bulletin of the NYU hospital for joint diseases.
[20] Christof Schütte,et al. Serum Peptidome Profiling Revealed Platelet Factor 4 as a Potential Discriminating Peptide Associated with Pancreatic Cancer , 2009, Clinical Cancer Research.
[21] M. Kohn,et al. Evidence-Based Diagnosis , 2009 .
[22] E. Diamandis,et al. Is early detection of cancer with circulating biomarkers feasible? , 2013, Clinical chemistry.
[23] Ya-li Liu,et al. Robot-Assisted Laparoscope Fundoplication for Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials , 2009, Digestion.
[24] Jen‐pei Liu,et al. Tests of equivalence and non‐inferiority for diagnostic accuracy based on the paired areas under ROC curves , 2006, Statistics in medicine.
[25] M. Ebell,et al. Evidence-Based Diagnosis , 2001, Springer New York.
[26] M. Pirmohamed,et al. Pharmacogenetic tests: the need for a level playing field , 2012, Nature Reviews Drug Discovery.
[27] Haifeng Jin,et al. Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles. , 2012, Clinical biochemistry.
[28] J. Knottnerus,et al. Assessment of the accuracy of diagnostic tests: the cross-sectional study. , 2003, Journal of clinical epidemiology.
[29] C. Yiannoutsos,et al. Ordered multiple‐class ROC analysis with continuous measurements , 2004, Statistics in medicine.
[30] Wei Zou,et al. Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. , 2010, Rapid communications in mass spectrometry : RCM.
[31] U. Ceglarek,et al. Challenges and developments in tandem mass spectrometry based clinical metabolomics , 2009, Molecular and Cellular Endocrinology.
[32] Markus Müller,et al. Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics? , 2009, Expert review of proteomics.
[33] E. Gold,et al. Epidemiology of and risk factors for pancreatic cancer. , 1995, The Surgical clinics of North America.
[34] A. Apituley. Assessment of Accuracy , 1997 .
[35] R. P. W. Duin,et al. A SIMPLIFIED VOLUME UNDER THE ROC HYPERSURFACE , 2008 .
[36] S. Baumann,et al. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2005, Clinical chemistry.
[37] Joachim Thiery,et al. Serum amino acid profiles and their alterations in colorectal cancer , 2011, Metabolomics.
[38] D. Ransohoff,et al. Sources of bias in specimens for research about molecular markers for cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] Sanjiv S Gambhir,et al. Mathematical Model Identifies Blood Biomarker–Based Early Cancer Detection Strategies and Limitations , 2011, Science Translational Medicine.
[40] H. Brenner,et al. [The early detection of cancer]. , 1972, Harefuah.
[41] Timothy D Veenstra,et al. How close is the bench to the bedside? Metabolic profiling in cancer research , 2009, Genome Medicine.
[42] M. Lerner,et al. Utility of Nuclear Magnetic Resonance Spectroscopy for Pancreatic Cancer Studies , 2012, Pancreas.
[43] William E Grizzle,et al. Serum Biomarker Panels for the Detection of Pancreatic Cancer , 2011, Clinical Cancer Research.
[44] E. Fukusaki,et al. Serum metabolomics as a novel diagnostic approach for pancreatic cancer , 2010, Metabolomics.
[45] E. Luebeck,et al. Biomarker-Based Early Cancer Detection: Is It Achievable? , 2011, Science Translational Medicine.
[46] Sayan Mukherjee,et al. Do serum biomarkers really measure breast cancer , 2009 .
[47] H. Weisberg. Sources of Bias , 2010 .
[48] M. Neumaier,et al. Functional protease profiling for diagnosis of malignant disease , 2012, Proteomics. Clinical applications.